Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification

NCT03832179 is registered in ClinicalTrials.gov with Bay Area Retina Associates as lead sponsor.

NCT NCT03832179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03832179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
Lead sponsor
Bay Area Retina Associates
Phase
Phase 4
Overall status
Completed
Start date
November 15, 2018
Completion date
March 30, 2024
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract, diabetic macular edema